Dr. Naresh Somani – Medical Oncologist in Jaipur

Dr. Naresh Somani is a senior Medical Oncologist practising in Jaipur, Rajasthan. He is associated with HCG Cancer Centre, Mansarovar, and Somani Hospital, where he provides comprehensive medical oncology care for patients with solid tumors and hematological malignancies.

He holds MBBS, MD in Internal Medicine and DM in Medical Oncology qualifications. He also underwent advanced training in Hemato-Oncology and Bone Marrow Transplantation at Royal Adelaide Hospital in Australia.

Dr. Naresh Somani has more than 33 years of overall clinical experience. His expertise includes chemotherapy, immunotherapy, targeted therapies, precision oncology and systemic treatment for complex and advanced cancers.

His clinical practice includes treatment of breast cancer, lung cancer, head and neck cancers, ovarian cancer, leukemia, lymphoma, multiple myeloma and other solid and blood cancers.

He also has extensive experience in bone marrow transplantation and management of hematological conditions such as leukemia, lymphoma, multiple myeloma and myelodysplastic syndromes.

Patients looking for a Medical Oncologist in Jaipur can consult Dr. Naresh Somani for cancer diagnosis review, chemotherapy planning, targeted therapy, immunotherapy, bone marrow transplant evaluation and long-term cancer follow-up.

Medical Oncology Consultation

Medical oncology consultation involves reviewing biopsy findings, scans, cancer stage, molecular test results and overall health to develop an appropriate systemic cancer treatment plan.

Chemotherapy

Chemotherapy uses anti-cancer medicines to destroy or control cancer cells. The medicine combination, dosage and treatment schedule are selected according to the type and stage of cancer.

Immunotherapy

Immunotherapy helps the immune system recognise and attack cancer cells and may be used for selected cancers depending on biomarkers, disease stage and previous treatments.

Targeted Therapy

Targeted therapy uses medicines designed to act on specific molecular abnormalities or proteins that support cancer growth and progression.

Breast Cancer Treatment

Medical treatment for breast cancer may include chemotherapy, hormonal therapy, targeted therapy and immunotherapy depending on receptor status, tumor biology and disease stage.

Lung Cancer Treatment

Lung cancer treatment may include chemotherapy, targeted medicines and immunotherapy based on the cancer subtype, molecular test results and stage.

Head & Neck Cancer Treatment

Systemic treatment for head and neck cancers may include chemotherapy, targeted therapy and immunotherapy either alone or in combination with surgery and radiation therapy.

Ovarian Cancer Treatment

Medical management of ovarian cancer may involve chemotherapy, targeted therapy and maintenance treatment depending on cancer stage, molecular findings and treatment response.

Leukemia Treatment

Leukemia treatment may include chemotherapy, targeted therapy, supportive care and bone marrow transplantation depending on the leukemia subtype and risk category.

Lymphoma Treatment

Lymphoma treatment is planned according to whether the disease is Hodgkin or non-Hodgkin lymphoma, its subtype, stage and overall patient condition.

Multiple Myeloma Treatment

Multiple myeloma treatment may include targeted medicines, immunomodulatory therapies, chemotherapy and stem cell transplantation depending on disease status and patient fitness.

Bone Marrow Transplant

Bone marrow transplantation may be considered for selected leukemias, lymphomas, multiple myeloma and other hematological disorders based on diagnosis, disease response and transplant eligibility.

Myelodysplastic Syndrome Treatment

Treatment of myelodysplastic syndromes depends on disease risk and may include supportive care, medicines, chemotherapy and bone marrow transplantation in suitable patients.

Advanced & Metastatic Cancer Treatment

Advanced and metastatic cancers may be managed using chemotherapy, targeted therapy, immunotherapy and supportive treatments selected according to cancer type, molecular profile and patient condition.